Leveraging gene editing technology, our platform is dedicated to developing a wide range of immune cell therapy products, including NK cells, CAR-NK, CAR-T, TIL, and other mixed immune cells.
Tailored for Preclinical and Phase I/II Clinical Trials, with continuous process exploration, optimization, and validation.
·Process Research
·Process Optimization and Validation
·Formulation and Process Development, Research, and Validation
·Research and Establishment of Quality Standards
·Development and Validation of Quality Analysis Methods
·Accelerated Stability Study
·Storage Stability Study
·Transport Stability Study
·In-Use Stability Study
·Production of Seed Cell Bank for Clinical Trial Registration Batch
·Preparation of End-of-Production Cell Bank for Clinical Trial Registration Batch
·Batch Quality Inspection
·Mechanism of Action Research
·Storage of Seed Cell Bank and Working Cell Bank
·Preclinical Toxicology Study Consulting
·Preclinical Pharmacodynamics Study Consulting
·CTD Document Preparation Consulting
·Process Optimization and Validation
·Formulation Process Optimization and Validation
·Optimization and Validation of Quality Standards
·Optimization and Validation of Quality Analysis Methods
·Storage Stability Studies
·In-Use Stability Studies
·Seed Cell Bank Production
·Working Cell Bank Production
·Batch Verification
·Clinical Trial Protocol Consulting
·Storage for Seed Cell Banks and Working Cell Banks
·Production Process Scale-up Research, Validation and Process Verification
·Validation and Verification of Quality Standards and Analytical Methods
·Storage Stability
·Production of Seed Cell Banks
·Production of Master Cell Banks
·Batch Quality Testing
·CTD Document Preparation Consulting
·Storage of Seed Cell Banks
·Storage of Master Cell Banks